+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 2Years +
All Genders
ID06153173

Evaluating Oral Mirdametinib Treatment for Langerhans Cell Histiocytosis and Related Histiocytic Disorders in Children and Adults

Led by Children's Hospital Medical Center, Cincinnati · Updated on 2026-09-21

40

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating mirdametinib as a treatment for patients with Langerhans cell histiocytosis LCH and other histiocytic disorders, which are rare blood diseases that often affect children, especially those under one year old. These diseases can cause bone lesions, skin rashes, and in severe cases, affect vital organs such as the liver, spleen, bone marrow, and central nervous system. Current chemotherapy treatments may not work well for all patients, especially those with risk-organ-positive disease, and the study aims to see if mirdametinib can provide better outcomes with fewer side effects. In this phase II trial, participants receive mirdametinib orally twice daily at a dose based on body surface area, with a maximum daily dose of 8 mg. Treatment cycles last four weeks and are given continuously, with doses spaced between 6 and 14 hours apart. The study focuses on one group of participants all receiving mirdametinib, with the primary goal of assessing the response rate after one year, which includes 13 cycles of treatment. Participants will be monitored throughout the study with PET scans or brain MRIs to measure disease, along with blood tests to check organ function and drug levels. The study will track how long the treatment response lasts, drug concentration in the blood, and safety measures. The total participation may last up to two years to observe long-term effects, with regular visits during treatment cycles to collect data and ensure adherence.

CONDITIONS

Brief Title

Mirdametinib in Histiocytic Disorders

Research Team

M

Monica Trapp

C

Caitlin Cottrell

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here